Company · CIK 0001228627 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Opus Genetics, Inc. · IRD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 FMForm 4 → | Sep 11, 4:09 pm EDT | George MagrathChief Executive Officer, Director | 467,698 | $1.93 | $901,960 | 2,048,485 | — | |
| Sep 8, 2026 MForm 4 → | Sep 8, 4:05 pm EDT | Cam GallagherDirector | 784,314 | $1.15 | $901,961 | 2,800,111 | — | |
| Sep 3, 2026 SForm 4 → | Sep 8, 4:05 pm EDT | Robert E. GagnonChief Financial Officer | 28,000 | $4.54 | $127,212 | 556,375 | −4.79% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 MForm 4 → | Sep 11, 4:09 pm EDT | George MagrathChief Executive Officer, Director | 392,157 | — | — | 0 | — | |
| Sep 8, 2026 MForm 4 → | Sep 8, 4:05 pm EDT | Cam GallagherDirector | 784,314 | — | — | 0 | — |